Skip to main content

Nuvalent, Inc.

NUVLDelisted Jul 15, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001861560

Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Nuvalent, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
4 insiders, $8.91M in total
Insiders trading
4
Net value
−$8.91M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Nuvalent, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Nuvalent, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Deerfield Management Company, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20263
Deerfield Mgmt L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Partners, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Flynn James EDirector, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20263
Deerfield Healthcare Innovations Fund, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Mgmt HIF, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Private Design Fund IV, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Mgmt IV, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Meyers Michael L.Director0Jul 15, 20262
Balcom AlexandraChief Financial Officer0Jul 15, 202614
Srivastava SapnaDirector0Jul 15, 20262
Oliger Christy J.Director0Jul 15, 20262
Squarer RonDirector0Jul 15, 20263
Turner Christopher DurantChief Medical Officer0Jul 15, 20262
Noci DarleneChief Development Officer0Jul 15, 202614
Lane BenjaminSee Remarks0Jul 15, 20262
Pelish Henry E.Chief Scientific Officer0Jul 15, 20268
Porter James RichardPresident and CEO0Jul 15, 20269
Miller Deborah AnnChief Legal Officer0Jul 15, 202612
Protopapas AnnaDirector0Jul 15, 20262
Bogle Grant C.Director0Jul 15, 20262
Wheeler CameronDirector0Jul 15, 20262
Shair MatthewDirector201,672IndirectNov 26, 20252
Pearlberg JosephDirector5,146Jun 20, 20250
Hack Andrew A. F.Director1,447,267IndirectDec 13, 20240
Conley EmilyDirector2,507Aug 27, 20240
Gilliland Dwight GaryDirector2,499Jun 14, 20240
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.10% Owner897,671Aug 3, 20210
Jackson Robert BowersDirector–Jul 30, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 4, 2021 (view filing)Aug 22 daysHack Andrew A. F.DirectorPPurchaseClass A Common Stock+735.0K$17.00+$12.5M+27.3%3.43M after
Aug 4, 2021 (view filing)6:05 PM ETAug 22 daysDeerfield Management Company, L.P. and 5 othersDirector, 10% Owner, Other: Director by DeputizationPPurchaseClass A Common Stock+600.0K$17.00+$10.2M–2.72M afterDerivative2 lots
Feb 16, 2022 (view filing)Feb 151 dayNoci DarleneSee RemarksSSale−4.20K$17.17−$72.1K−100.0%0 after
Jul 8, 2022 (view filing)Jul 71 dayNoci DarleneSee RemarksSSaleClass A Common Stock−16.8K$17.61−$295.8K−100.0%0 after
Jul 15, 2022 (view filing)Jul 13-152 daysShair MatthewDirectorSSaleClass A Common Stock−2.10K$18.29−$38.4K−0.1%2.16M after2 lots
Jul 19, 2022 (view filing)Jul 15-194 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.20K$17.26−$72.5K−100.0%0 after4 lots
Aug 17, 2022 (view filing)Aug 152 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−2.60K$17.02−$44.2K−100.0%0 after
Aug 25, 2022 (view filing)Aug 241 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−1.60K$17.03−$27.3K−100.0%0 after
Sep 16, 2022 (view filing)Sep 151 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.20K$18.14−$76.2K−100.0%0 after
Sep 16, 2022 (view filing)Sep 14-152 daysShair MatthewDirectorSSaleClass A Common Stock−18.8K$18.35−$345.1K−0.9%2.14M after2 lots
Oct 7, 2022 (view filing)Oct 5-72 daysShair MatthewDirectorSSaleClass A Common Stock−29.1K$18.93−$550.9K−1.4%2.11M after4 lots
Oct 14, 2022 (view filing)Oct 14Same dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.20K$21.41−$89.9K−100.0%0 after
Nov 1, 2022 (view filing)Oct 284 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−8.97K$38.86−$348.5K−100.0%0 after2 lots
Nov 1, 2022 (view filing)Oct 284 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−1.00K$40.25−$40.3K−100.0%0 after
Nov 3, 2022 (view filing)Nov 3Same dayHack Andrew A. F.DirectorPPurchaseClass A Common Stock+149.3K$33.50+$5.00M+4.4%3.58M after
Nov 4, 2022 (view filing)Nov 2-32 daysShair MatthewDirectorSSaleClass A Common Stock−133.4K$31.35−$4.18M−6.3%1.98M after8 lots
Nov 7, 2022 (view filing)6:24 PM ETNov 34 daysDeerfield Management Company, L.P. and 7 othersDirector, 10% Owner, Other: * Director by deputizationPPurchaseClass A Common Stock+650.0K$33.50+$21.8MNew position650.0K after
Nov 17, 2022 (view filing)Nov 152 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.20K$31.99−$134.4K−100.0%0 after3 lots
Nov 17, 2022 (view filing)Nov 152 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$31.91−$63.8K−100.0%0 after3 lots
Dec 9, 2022 (view filing)Dec 72 daysShair MatthewDirectorSSaleClass A Common Stock−18.3K$31.17−$570.5K−0.9%1.96M after2 lots
Dec 16, 2022 (view filing)Dec 151 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−4.20K$29.91−$125.6K−100.0%0 after3 lots
Dec 16, 2022 (view filing)Dec 151 dayMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$29.98−$60.0K−100.0%0 after3 lots
Jan 6, 2023 (view filing)Jan 42 daysShair MatthewDirectorSSaleClass A Common Stock−18.3K$28.04−$513.1K−0.9%1.94M after2 lots
Jan 19, 2023 (view filing)Jan 172 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$32.62−$65.2K−100.0%0 after2 lots
Feb 3, 2023 (view filing)Feb 21 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.00K$29.56−$88.7K−100.0%0 after2 lots
Feb 17, 2023 (view filing)Feb 152 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$29.56−$59.1K−100.0%0 after2 lots
Mar 3, 2023 (view filing)Mar 12 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.00K$29.88−$89.6K−100.0%0 after2 lots
Mar 17, 2023 (view filing)Mar 152 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$28.25−$56.5K−100.0%0 after2 lots
Apr 5, 2023 (view filing)Apr 32 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.00K$26.59−$79.8K−100.0%0 after2 lots10b5-1
Apr 19, 2023 (view filing)Apr 172 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$30.10−$60.2K−100.0%0 after2 lots10b5-1
May 3, 2023 (view filing)May 12 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−900$39.61−$35.6K−100.0%0 after10b5-1
May 3, 2023 (view filing)May 12 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.00K$38.60−$115.8K−100.0%0 after5 lots10b5-1
May 9, 2023 (view filing)May 5-94 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−4.13K$39.64−$163.8K−100.0%0 after2 lots10b5-1
May 17, 2023 (view filing)May 152 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$40.74−$81.5K−100.0%0 after2 lots10b5-1
Jun 2, 2023 (view filing)Jun 11 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.00K$42.64−$127.9K−100.0%0 after3 lots10b5-1
Jun 7, 2023 (view filing)Jun 52 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−600$45.00−$27.0K−100.0%0 after10b5-1
Jun 7, 2023 (view filing)Jun 52 daysTurner Christopher DurantChief Medical OfficerSSaleClass A Common Stock−10.2K$44.86−$459.1K−41.4%14.5K after10b5-1
Jun 20, 2023 (view filing)Jun 155 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$44.28−$88.6K−100.0%0 after3 lots10b5-1
Jun 20, 2023 (view filing)Jun 15-165 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.90K$45.16−$176.1K−100.0%0 after2 lots10b5-1
Jul 6, 2023 (view filing)Jul 33 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.00K$41.48−$124.4K−100.0%0 after2 lots10b5-1
Jul 19, 2023 (view filing)Jul 172 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$43.06−$86.1K−100.0%0 after3 lots10b5-1
Jul 21, 2023 (view filing)Jul 19-202 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−15.5K$45.13−$699.5K−100.0%0 after2 lots10b5-1
Jul 24, 2023 (view filing)Jul 20-244 daysTurner Christopher DurantChief Medical OfficerSSaleClass A Common Stock−300$46.81−$14.0K−2.0%14.5K after2 lots10b5-1
Jul 28, 2023 (view filing)Jul 26-282 daysTurner Christopher DurantChief Medical OfficerSSaleClass A Common Stock−5.03K$47.95−$241.2K−25.7%14.5K after2 lots10b5-1
Aug 1, 2023 (view filing)Jul 284 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−6.50K$48.52−$315.4K−100.0%0 after10b5-1
Aug 1, 2023 (view filing)Jul 311 dayBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−25.0K$48.99−$1.22M−100.0%0 after2 lots10b5-1
Aug 1, 2023 (view filing)Aug 1Same dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.00K$49.95−$149.8K−100.0%0 after2 lots10b5-1
Aug 17, 2023 (view filing)Aug 152 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$42.65−$85.3K−100.0%0 after2 lots10b5-1
Sep 6, 2023 (view filing)Sep 15 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.00K$46.56−$139.7K−100.0%0 after2 lots10b5-1
Sep 19, 2023 (view filing)Sep 154 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−2.00K$47.64−$95.3K−100.0%0 after2 lots10b5-1